NOKIA:OMXHEXNokia Oyj Analysis
Data as of 2026-03-10 - not real-time
€6.81
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Nokia shares are currently trading at €6.81, comfortably above the 20‑day (≈€6.41), 50‑day (≈€5.95) and 200‑day (≈€4.89) simple moving averages, signalling a strong bullish bias. The price sits near the technical resistance around €7.15 while a solid support zone exists near €5.80, and the MACD line has just crossed above its signal, reinforcing upward momentum. Momentum remains robust with an RSI of roughly 63, indicating the stock is approaching overbought levels but still has room to run. Volume is on an increasing trend, providing liquidity for short‑term moves, yet the 30‑day volatility is elevated at over 50%, suggesting price swings could be sizable. Fundamentally, the trailing P/E of about 62 dwarfs the industry average of 37, pointing to a potentially overvalued market price, while the DCF fair‑value estimate of €1.74 is dramatically lower than today’s price, underscoring a valuation gap. The dividend yield of 1.79% looks attractive, but a payout ratio exceeding 100% raises concerns about sustainability. Nokia’s beta is modest (≈0.33), indicating limited systematic risk, though its exposure to global telecom cycles adds sector‑specific risk. The upcoming Annual General Meeting in early February could bring governance or strategic updates that may move the stock. Overall, the technical picture is bullish, but fundamentals suggest caution.
Given this mix, a prudent short‑term stance is to monitor the proximity to the €7.15 resistance and consider trimming exposure if price tests that level, while the medium term remains a hold as the company works to align earnings growth with its lofty valuation. Long‑term investors may find upside if the market corrects toward the DCF estimate and the dividend payout becomes more sustainable, making the stock a potential value play once pricing normalises.
Given this mix, a prudent short‑term stance is to monitor the proximity to the €7.15 resistance and consider trimming exposure if price tests that level, while the medium term remains a hold as the company works to align earnings growth with its lofty valuation. Long‑term investors may find upside if the market corrects toward the DCF estimate and the dividend payout becomes more sustainable, making the stock a potential value play once pricing normalises.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Price approaching technical resistance
- High short‑term volatility
- Overvalued trailing P/E
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Bullish trend confirmed by moving averages
- Increasing volume supporting liquidity
- Uncertain dividend sustainability
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Potential valuation correction toward DCF fair value
- Diversified global footprint reducing single‑region exposure
- Strategic 5G and network services growth opportunities
Key Metrics & Analysis
Financial Health
Revenue Growth2.40%
Profit Margin3.27%
P/E Ratio61.9
ROE3.05%
ROA2.50%
Debt/Equity20.97
P/B Ratio1.8
Op. Cash Flow€2.1B
Free Cash Flow€499.1M
Industry P/E37.0
Technical Analysis
TrendBullish
RSI63.0
Support€5.80
Resistance€7.15
MA 20€6.41
MA 50€5.95
MA 200€4.89
MACDBullish
VolumeIncreasing
Fear & Greed Index78.13
Valuation
Fair Value€1.74
Target Price€6.00
Upside/Downside-11.97%
GradeOvervalued
TypeBlend
Dividend Yield1.79%
Risk Assessment
Beta0.33
Volatility50.73%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.